PrEP iT! A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care
PrEP iT! A Pilot Test of a Mobile Peer Support Intervention to Optimize PrEP Adherence and Retention in PrEP Care
批准号:
10116478
负责人:
Jason V Baker
金额:
$20.67万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-08 至 2023-11-30
关键词:
AIDS preventionAddressAdherenceAdoptionAgeAppointmentAreaBehavioralBehavioral SciencesBiologicalBloodCar PhoneCaringClinicalClinical TrialsCollaborationsCommunicationCommunitiesContinuity of Patient CareDataDevelopmentDoseEffectivenessEpidemiologyFeedbackFocus GroupsGoalsHIVHIV InfectionsHIV SeropositivityHIV diagnosisHealthHealth PersonnelHealthcareHispanicsInfectionInterventionInterviewLatinoModelingMonitorMoodsMotivationOutcomeOutcome StudyPatient Self-ReportPersonsPreparationPrevention approachPrevention strategyPreventiveProceduresProcessProgram SustainabilityProtective AgentsRandomizedRandomized Controlled TrialsRecommendationReportingResearchScienceSexual HealthSuggestionSupport GroupsTarget PopulationsTaste PerceptionTechnologyTenofovirTestingText MessagingTimeYouthage groupagedantiretroviral therapyarmclinical carecommunity settingemtricitabineethnic minority populationexperiencefollow-upforgettinghigh risk populationimprovedinfection rateinnovationmedication compliancemembermenmen who have sex with menmobile computingmultidisciplinarynovelopen labelopen sourcepeerpeer supportpillpre-exposure prophylaxisracial minorityscale upskillssocial stigmatheoriestherapy designtooltreatment as usualtruvadausabilityvirtualyoung adultyoung men who have sex with men
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Young men who have sex with men (YMSM), especially those who are Black and Hispanic/Latino, are
disproportionately impacted by new HIV infections. Pre-exposure prophylaxis (PrEP) is one of the most
effective HIV prevention tools, however its benefits are directly correlated with medication adherence to sustain
adequate tenofovir (TFV) levels in blood. Recent studies (ATN 110 & 113) show that young MSM prescribed
PrEP struggle with adherence, especially when healthcare appointments are reduced from monthly to every 3
months, and most fail to maintain protective drug levels via PrEP over time. This has prompted calls for youth-
specific interventions consisting of peer support groups and frequent healthcare interactions for YMSM on
PrEP. The proposed study responds directly these recommendations by developing and pilot testing a mobile
peer support intervention to improve PrEP adherence and retention in PrEP care for YMSM ages 18-29 years,
called “PrEP it Together” (or PrEP iT!). PrEP iT! is grounded in the principles of the Technology Adoption
Model and the Information, Motivation, and Behavioral Skills (IMB) model and includes virtual peer interaction
and support, youth-centered PrEP and sexual health information, adherence reminders and self-monitoring,
text message follow-up for youth whose adherence may be faltering, healthcare appointment reminders,
healthcare provider interactions, and gamification components to optimize engagement. First, we will develop
the PrEP iT! mobile intervention through focus groups with YMSM and refine iterations through input
from a community advisory board (CAB). Four focus groups will be conducted to gain feedback on an
existing mobile platform from which PrEP iT! will be adapted. Next, a CAB of YMSM will provide regular
feedback during the iterative intervention design process. Usability testing with 6 members of the target
population will be conducted, culminating in a final version of PrEP iT! Second, in preparation for a
subsequent R01 trial, we will conduct a pilot randomized controlled trial to assess the feasibility,
acceptability and preliminary impact of the PrEP iT! intervention for YMSM. Eighty YMSM recently
initiating or restarting PrEP will be randomized to receive either PrEP iT! or usual care for 6 months, with
biological and self-reported outcomes collected at baseline, and 3- and 6-month follow-up time points.
Intervention use data will be collected to assess which intervention components impact study outcomes. Exit
interviews of 10 YMSM will be conducted to further refine the intervention for a larger trial. PrEP iT! is
innovative because it is the first intervention to use mobile phone technology to facilitate virtual peer support for
YMSM on PrEP. The study advances PrEP science by addressing critical gaps (adherence & retention) in
PrEP care among YMSM, and is sustainable because it will be built on an open source platform that may be
integrated into clinical and community settings serving YMSM. If the PrEP iT! intervention is demonstrated to
be effective, it may be quickly scaled up for wide-scale dissemination.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Attitudes Toward and Beliefs in the Effectiveness of Biomedical HIV Prevention Strategies Among Emerging and Young Adult Sexual Minority Men.
新兴和年轻性少数男性对生物医学艾滋病毒预防策略有效性的态度和信念。
DOI:
10.1007/s12529-023-10244-4
发表时间:
2023
期刊:
International journal of behavioral medicine
影响因子:
2.7
作者:
[Ma,Junye, Chase,GregoryE, Black,Ashley, Klaphake,Jonathan, Garcia-Myers,Kelly, Baker,JasonV, Horvath,KeithJ]
通讯作者:
Horvath,KeithJ
Immunologic basis of cardiac disease after severe COVID-19
-
批准号:10442251
-
项目类别:
-
资助金额:$69.46万
-
财政年份:2022
-
负责人:Jason V Baker
-
依托单位:
Immunologic basis of cardiac disease after severe COVID-19
-
批准号:10650182
-
项目类别:
-
资助金额:$68.5万
-
财政年份:2022
-
负责人:Jason V Baker
-
依托单位:
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV
-
批准号:10693938
-
项目类别:
-
资助金额:$68.86万
-
财政年份:2022
-
负责人:Jason V Baker
-
依托单位:
Optimization of a behavioral intervention to increase physical activity in older adults living with HIV
-
批准号:10481551
-
项目类别:
-
资助金额:$73.53万
-
财政年份:2022
-
负责人:Jason V Baker
-
依托单位:
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
-
批准号:10685376
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2021
-
负责人:Jason V Baker
-
依托单位:
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
-
批准号:10325041
-
项目类别:
-
资助金额:$53.8万
-
财政年份:2021
-
负责人:Jason V Baker
-
依托单位:
Treatment to reduce inflammation and improve immune recovery among older HIV pts
-
批准号:8641495
-
项目类别:
-
资助金额:$51.38万
-
财政年份:2014
-
负责人:Jason V Baker
-
依托单位:
Treatment to reduce inflammation and improve immune recovery among older HIV pts
-
批准号:9038208
-
项目类别:
-
资助金额:$55.9万
-
财政年份:2014
-
负责人:Jason V Baker
-
依托单位:
Treatment to reduce inflammation and improve immune recovery among older HIV pts
-
批准号:8883185
-
项目类别:
-
资助金额:$5.25万
-
财政年份:2014
-
负责人:Jason V Baker
-
依托单位:
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease
-
批准号:8846913
-
项目类别:
-
资助金额:$63.86万
-
财政年份:2014
-
负责人:Jason V Baker
-
依托单位:
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease
-
批准号:9281047
-
项目类别:
-
资助金额:$43.33万
-
财政年份:2014
-
负责人:Jason V Baker
-
依托单位:
Targeted anticoagulant therapy to reduce inflammation in treated HIV disease
-
批准号:9068239
-
项目类别:
-
资助金额:$66.79万
-
财政年份:2014
-
负责人:Jason V Baker
-
依托单位:
海外基金